Instituto do Cancer do Estado de São Paulo
103
21
25
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
10.7%
11 terminated/withdrawn out of 103 trials
71.8%
-14.7% vs industry average
10%
10 trials in Phase 3/4
0%
0 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (103)
Cold and NSAID Trial for Prevention of Post-ERCP Pancreatitis
Role: lead
Intralesional Steroid Injection Versus Oral Prednisolone in Prevention of Esophageal Stricture
Role: lead
Comparative Study Between (FC-SEMS) and (PC-SEMS) in the Palliation of Dysphagia Due to Malignant Neoplasm of Esophagus.
Role: lead
Comparison of 0.4% Hyaluronic Acid Solution Versus Hydroxyethylamide Solution in Submucosal Endoscopic Resections
Role: lead
Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures
Role: lead
Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions
Role: lead
Percutaneous Biopsy After Neoadjuvant Chemotherapy.
Role: lead
Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy
Role: collaborator
Evaluation of Persistent Infection by Oncogenic Human Papillomavirus (HPV) in Patients Treated for Cervical Carcinoma and Its Relation to Prognostic Factors
Role: lead
Phase I Study of Docetaxel and 177-Lutetium-PSMA-I&T in First-Line Treatment for Patients With Metastatic Castration-Resistant Prostate Adenocarcinoma
Role: lead
Agnostic Therapy in Rare Solid Tumors
Role: lead
Dose-escalation of Regorafenib in Advanced Hepatocellular Carcinoma
Role: lead
Effectiveness and Performance of an Optical Biopsy Technology for Esophageal Cancer in Brazil and the United States
Role: collaborator
Detecting Clinically Significant Prostate Cancer With Advanced MRI Protocols and Extensive Histopathology
Role: collaborator
Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS)
Role: lead
Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes
Role: lead
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
Role: collaborator
Neurolytic Block Techniques In Abdominal Visceral Cancer Pain
Role: lead
Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Role: lead
Benign Migratory Glossitis Associated With Antiangiogenic Drugs
Role: lead